Ontario medication guide

Start with the symptom, safety concern, and prescriber, not a medication list

No medication treats autism itself. A clinician may consider medication for a co-occurring concern such as anxiety, ADHD, irritability, sleep difficulty, or obsessive-compulsive symptoms. The right next step is a clear discussion of the goal, possible benefits, risks, monitoring, and alternatives for one person.

First question

What is changing?

Describe the symptom, its impact, what has been tried, and any safety concern.

Before a change

Confirm the plan

Ask what to monitor, when to review, and which effects need prompt attention.

Updated:

A cautious decision path

Medication decisions are individualized and require follow-up.

This page is educational information, not a diagnosis or treatment plan. Do not start, change, or stop a prescription without prescriber guidance.

What Medication Can and Cannot Do

Understanding the role of medication in autism care is essential before starting any prescription. Medication may be used alongside behavioural, communication, or other supports when a qualified prescriber considers it appropriate.

What Medication Can Help With

  • May help with irritability or unsafe behaviours for some people
  • May help with attention or impulsivity when ADHD symptoms are present
  • May be considered for anxiety, panic, sleep, or obsessive-compulsive symptoms
  • May support mood symptoms when a co-occurring mood disorder is assessed
  • May make other supports more accessible for some people; response varies

What Medication Cannot Do

  • Treat or cure autism itself, no such medication exists
  • Replace behavioural therapy, OT, speech therapy, or other supports
  • Improve social skills or communication directly
  • Eliminate sensory processing differences
  • Work as a long-term standalone solution without regular review
  • Be changed or stopped without a prescriber-led follow-up plan
  • Guarantee the same response in every individual, effects vary widely

Common Medications by Target Symptom

The following medications are commonly used in Ontario for autistic individuals. This is not a complete list. Prescribing decisions are individualized based on the person's specific symptoms, medical history, and other factors.

Irritability, Aggression & Self-Injury

Antipsychotics (Atypical)

Some products in this class have product-specific regulatory indications; confirm the current monograph and target symptom with the prescriber.

Risperidone (Risperdal)

  • Product-specific indication and age limits vary; check the current monograph
  • May be considered for irritability-related symptoms after clinical assessment
  • Available as tablet, liquid, and orally dissolving tablet
  • Common side effects: weight gain, sedation, increased appetite
  • Ask the prescriber which metabolic monitoring is appropriate
  • Covered on Ontario Drug Benefit (ODB) formulary

Aripiprazole (Abilify)

  • Product-specific indication and age limits vary; check the current monograph
  • Side-effect profiles differ; discuss risks and monitoring with the prescriber
  • May cause restlessness (akathisia) in some individuals
  • Available as tablet and liquid formulation
  • Common side effects: weight gain, sedation, increased appetite
  • Covered on Ontario Drug Benefit (ODB) formulary
ADHD Symptoms: Attention, Impulsivity, Hyperactivity

ADHD Medications

ADHD may co-occur with autism. Stimulants and non-stimulants are both used, though response and side effects vary by person and should be reviewed with a prescriber.

Methylphenidate (Ritalin, Biphentin, Concerta)

Stimulant
  • First-line for ADHD symptoms in many cases
  • Immediate and extended-release formulations available
  • Ask the prescriber when and how effects will be reviewed
  • Side effects: appetite suppression, sleep difficulties, irritability
  • Covered on ODB formulary

Guanfacine (Intuniv)

Non-Stimulant
  • Extended-release alpha-2 agonist
  • Useful when stimulants cause significant side effects
  • Can reduce both ADHD symptoms and irritability
  • Review timing varies; follow the prescriber’s plan
  • Side effects: sedation, low blood pressure

Atomoxetine (Strattera)

Non-Stimulant
  • Non-controlled substance; preferred in some situations
  • Review timing varies; follow the prescriber’s plan
  • Also has some antidepressant properties
  • Side effects: nausea, appetite changes, mood changes
  • Ask the prescriber how to stop safely; do not change the prescription independently
Anxiety, OCD & Depression

SSRIs and Anxiolytics

Anxiety and obsessive-compulsive symptoms may co-occur with autism. Evidence for SSRIs is mixed, so the decision and monitoring plan should be individualized with a prescriber.

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Fluoxetine (Prozac), most studied SSRI in autism
  • Sertraline (Zoloft), commonly prescribed for anxiety and OCD
  • Escitalopram (Cipralex), well-tolerated, used for anxiety
  • Review timing varies; follow the prescriber’s plan
  • Ask the prescriber how to stop safely; do not change the prescription independently
  • Some people experience increased agitation or activation when starting; ask the prescriber how this should be monitored

Other Anxiolytics

  • Buspirone, non-habit-forming option for generalized anxiety
  • Clonidine, alpha-2 agonist; used for anxiety, sleep, and ADHD
  • Melatonin, widely used for sleep onset difficulties; available OTC
  • Hydroxyzine, antihistamine used short-term for acute anxiety
  • Benzodiazepines, generally avoided long-term due to tolerance and dependence risk
  • Propranolol, sometimes used for performance anxiety or activation

Monitoring and Safety

Safe medication use requires a prescriber-led plan for expected effects, side effects, interactions, and follow-up. The appropriate checks depend on the person, medication, dose, and treatment goal.

Antipsychotic Monitoring (Risperidone / Aripiprazole)

  • Before starting: Ask which health history, measurements, laboratory checks, or movement assessments are appropriate for this medication
  • During treatment: Agree on what to monitor, which side effects need prompt attention, and how results will be shared
  • At follow-up: Review response, side effects, dose, interactions, and whether continuing remains appropriate with the prescriber

Source: Canadian Paediatric Society, Antipsychotic Use in Children and Youth (2022)

ADHD Medication Monitoring

  • Before starting: Ask which health history, measurements, and symptom measures are appropriate for this medication
  • After a change: Agree on how to review symptom response, side effects, interactions, and any dose change
  • At follow-up: Review growth, blood pressure, symptoms, and whether continuing remains appropriate with the prescriber

Source: Canadian Paediatric Society, ADHD in Children and Youth (2018)

Ontario Drug Coverage Programs

Ontario has several programs that cover prescription medication costs. Eligibility depends on age, income, and existing drug benefit coverage.

Access and coverage

Confirm the current route

Access to developmental pediatrics varies by region and referral route. Confirm the current intake estimate directly. Coverage depends on the medication, eligibility, and current program rules. Use the official links below to confirm the formulary and application requirements.

OHIP+

Ontario Health Insurance Plan (Under 25)

Covers most prescription drugs on the Ontario Drug Benefit formulary at no cost for Ontarians under 25 who do not have another drug benefit plan.

  • No deductible or co-pay for eligible individuals
  • Must not have employer or private drug coverage
  • Covers most common autism-related medications

ODB

Ontario Drug Benefit Program

Covers prescription drugs for eligible groups including Ontario Works recipients, ODSP recipients, Trillium Drug Program registrants, and others.

  • Co-pay and prior-approval rules depend on the eligibility category
  • Some medications require prior approval (Limited Use)
  • Eligibility through ODSP, OW, or Trillium

Trillium

Trillium Drug Program

Helps Ontario residents of any age with high drug costs relative to their household income.

  • Deductible depends on household income and current program rules
  • No age limit, available to all Ontario residents
  • After deductible met, ODB covers the rest of the year
OHIP+: Learn More ODB: Learn More Trillium: Learn More

Working with Your Prescriber

In Ontario, several types of medical professionals can prescribe medications for autism-related conditions. Building a collaborative relationship with your prescriber makes it easier to review goals, benefits, side effects, and next steps.

Types of Prescribers in Ontario

  • Developmental Pediatrician

    Most specialized for autism medication management. Conducts formal assessments and coordinates care. Ask the centre about current referral and intake conditions.

  • Child and Adolescent Psychiatrist

    Specializes in mental health co-occurring conditions. Can manage complex medication regimens and provide psychiatric assessment. Access through hospital outpatient or community programs.

  • Pediatrician

    Can manage first-line medications (ADHD medications, melatonin) and refer to specialists for complex needs. Most accessible.

  • Family Physician

    Can initiate and manage straightforward medications with specialist guidance. Comfort level with autism medications varies significantly.

Questions to Ask Your Prescriber

  • What condition are we targeting with this medication?
  • What is the expected timeline to see if it is working?
  • What are the most common side effects I should watch for?
  • What monitoring tests will be needed and how often?
  • What is the plan if this medication does not work or causes side effects?
  • Is this medication covered by OHIP+ or ODB?
  • If stopping is considered, what follow-up plan is needed?
  • How does this interact with any other medications my child takes?

Frequently Asked Questions

Find a Specialist and Access Support

Medication decisions work best alongside therapy and support. Our provider directory can help you find developmental pediatricians, psychiatrists, and other specialists across Ontario.

Find a Provider Near YouDaily Life with Autism Hub

Take Action

Help End the Wait

Ontario families assembled this evidence from the government’s own records. Put it to work.

Email Your MPP (2 min)Share Your Story

Verified references and sources

Official Government Sources

  • [2024]
    Autism spectrum disorder among children and youth in Canada 2019Government Record
    Public Health Agency of Canada • Government • 2024-03-26
    View

Official Organizations

  • [2025]
    Autism Spectrum Disorders Fact Sheet (updated September 17, 2025)Government Record
    World Health Organization (WHO) • Official • 2025-09-17
    View

Related Resources

Citable facts from this page(6)

What does the WHO say about early autism intervention timing?

Verified

The WHO Fact Sheet on Autism Spectrum Disorders (updated Sept. 17, 2025) states that timely access to early evidence-based psychosocial interventions can improve the ability of autistic children to communicate effectively and interact socially. Dawson et al. (2010, Pediatrics; PMID 19948568) confirmed in an RCT that ESDM (Early Start Denver Model) at 18–30 months produced significant developmental gains.

Source: WHO Fact Sheet: Autism Spectrum Disorders (updated Sept. 17, 2025); Dawson et al., Pediatrics 2010 (PMID 19948568) · Open source record

What autism services are available in Ontario while waiting for OAP?

Verified

While waiting for OAP Core Clinical Services, families can access: Foundational Family Services (free, no waitlist), school-based IEP supports, Preschool Speech and Language programs, EarlyON Child and Family Centres, private therapy (if financially able), and DSO registration for transition planning.

Source: Ontario Autism Program · Open source record

What free autism resources are available in Ontario?

Verified

Free autism resources in Ontario include: EarlyON Child and Family Centres (drop-in), Preschool Speech and Language (assessment/therapy), OAP Caregiver Workshops (training), and Foundational Family Services. These are available without the main OAP waitlist but do not replace intensive clinical therapy.

Source: Ontario.ca · Open source record

How many children are on the Ontario autism waitlist?

Verified

Latest FOI data shows 91,974 children are registered in the Ontario Autism Program (May 2026), while 22.5% have active funding agreements. [FOI] An active funding agreement does not mean a child is receiving services; it is an administrative status distinct from service delivery. The Ontario Autism Coalition reported in July 2026 that some families in its community had waited more than five years. That report is not a province-wide average. Last verified: 2026-08-10

Source: MCCSS FOI data via Ontario Autism Coalition [OAC] · Open source record

What makes End The Wait Ontario different from other autism resources?

Verified

End The Wait Ontario analyzes Ontario's autism waitlist crisis using verified program data from Freedom of Information requests filed by the Ontario Autism Coalition (Dec 2025) and CBC News (Jan 2026), and the FAO. [FOI] Because this platform aggregates ministry and watchdog figures in one place, parents and advocates can monitor the crisis in real time and hold decision‑makers accountable. Last verified: 2026-08-10

Source: Financial Accountability Office of Ontario [FAO] & FOI Data · Open source record

Why is there such a long waitlist?

Verified

FAO spending‑plan reviews show that, even as 91,974 children are registered in the OAP (May 2026), only 22.5% have active funding agreements. [FOI] This structural underfunding creates a permanent backlog: each year, more children join the waitlist than transition into therapy.

Source: Financial Accountability Office of Ontario [FAO] & FOI Data · Open source record

Sources on this page

The source chain stays visible.

Key claims are paired with their source, evidence tier, and verification date so readers can inspect the public record directly.

Facts3
Sources2

1 in 50

According to the 2019 Canadian Health Survey on Children and Youth, about 1 in 50 children and youth aged 1 to 17 in Canada had an autism diagnosis

Primary sourcePublic Health Agency of Canada (2024)Verified 2024-03-26

WHO recommends accessible, community-based early interventions for children with autism. Timely evidence-based psychosocial interventions improve communication and social engagement

Primary sourceWorld Health Organization (2025)Verified 2025-09-17
Last system verification: 2026-08-10. Next scheduled update: 2026-11-05.
View methodologyBrowse every source

About this page

See authorship, freshness, trust signals, and ways to stay current.

Written by

Founder & Autism Advocate

Parent of autistic child navigating OAP system